NCT00322582

Brief Summary

In many of the patients with cardiomyopathy, the etiology is not clear . In about 30% there is a family history of cardiomyopathy .Our aim is to study the genetics basis for these patients with cardiomyopathy with no clear etiology and who have a first degree family relative with cardiomyopathy as well.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2007

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 5, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

May 8, 2006

Completed
12 months until next milestone

Study Start

First participant enrolled

May 1, 2007

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2009

Completed
Last Updated

January 25, 2012

Status Verified

January 1, 2007

Enrollment Period

1.8 years

First QC Date

May 5, 2006

Last Update Submit

January 24, 2012

Conditions

Keywords

familial cardiomyopathygenetics analysis

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

History of cardiomyopathy

You may qualify if:

  • history of cardiomyopathy
  • etiology not known
  • family history of cardiomyopathy
  • ability to understand and sign the informed consent

You may not qualify if:

  • refusal to participate
  • pregnancy
  • current participation in another active treatment study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carmel Medical Center

Haifa, 34362, Israel

Location

Related Publications (1)

  • Murphy RT, Starling RC. Genetics and cardiomyopathy: where are we now? Cleve Clin J Med. 2005 Jun;72(6):465-6, 469-70, 472-3 passim. doi: 10.3949/ccjm.72.6.465.

    PMID: 16018289BACKGROUND

Biospecimen

Retention: SAMPLES WITH DNA

Blood samples

MeSH Terms

Conditions

Cardiomyopathies

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Study Officials

  • Offer Amir, MD

    Lady Davis Carmel Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
FAMILY BASED
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Offer Amir, MD, Carmel Medical Center

Study Record Dates

First Submitted

May 5, 2006

First Posted

May 8, 2006

Study Start

May 1, 2007

Primary Completion

February 1, 2009

Study Completion

February 1, 2009

Last Updated

January 25, 2012

Record last verified: 2007-01

Locations